Geneta Biosolutions offers advanced end-to-end clinical genomics services from sequencing to interpretation through its CAP and NABL accredited genomic laboratories. The genomics date are further analyzed using popular enterprise cloud-based clinical genomics software platform.
We offer a wide range of oncology and hereditary tests to address the growing demand for molecular profiling for targeted therapies. Advanced molecular profiling is used to correlate specific genetic alterations helping the clinicians to use effective targeted therapies, to drive the new era of personalized medicine.
Tests offered:
- Whole /Clinical Exome (WES/CES)
- Targeted panels (Oncology, Inherited disorders etc.)
- Whole Genome (WGS)
Testing services offered for following disease categories
Cardiology
Endocrinology
Gastrointestinal
Hematology
Metabolism
Nephrology
Neurology
Oncology
Ophthalmology
Pulmonology
Reproductive
Rare genetic disorders